BioStock: Saniona's CEO on progress in 2020 and the way forward

Saniona achieved several milestones last year, initiating a transformation of the company, which is the central conclusion of the company’s annual report for 2020. Most notably, a new business strategy was established under the leadership of President and CEO Rami Levin, who took up his position at the beginning of the year. Saniona also achieved significant progress in its ongoing clinical studies with drug candidate Tesomet, raised 65 million USD in a directed share issue and recruited a complete and experienced US-based management team. BioStock reached out to CEO Levin for a comment. 

Read the full interview with Rami Levin at biostock.se:

https://www.biostock.se/en/sanionas-ceo-on-progress-in-2020-and-the-way-forward/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se